Filing Details
- Accession Number:
- 0001209191-19-000224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-02 16:03:40
- Reporting Period:
- 2019-01-02
- Accepted Time:
- 2019-01-02 16:03:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1337553 | Aerie Pharmaceuticals Inc | AERI | Biological Products, (No Disgnostic Substances) (2836) | 203109565 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590001 | C. Casey Kopczynski | C/O Aerie Pharmaceuticals, Inc. 4301 Emperor Blvd., Suite 400 Durham NC 27703 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-02 | 11,000 | $35.21 | 106,743 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to the reporting person's Rule 10b5-1 plan.
- The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions pursuant to the reporting person's Rule 10b5-1 plan at prices ranging from $35.00 to $35.54, inclusive.
Billionaire Hedge Funds
